S01ED51 • dorzolamide + timolol • Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents
The combination of Dorzolamidum + Timololum is used for the treatment of glaucoma and ocular hypertension in patients who do not respond adequately to monotherapy. Dorzolamidum is a carbonic anhydrase inhibitor, and Timololum is a beta-blocker; together, they reduce intraocular pressure through complementary mechanisms.
The medication is available as eye drops and is usually administered twice daily, according to the doctor's instructions. It is effective in preventing optic nerve damage and preserving vision.
Side effects may include burning or stinging sensation in the eyes, bitter taste, dry eyes, fatigue, and, in rare cases, allergic reactions. Regular monitoring of intraocular pressure is essential.
Consult your doctor to discuss the benefits and risks of treatment with this combination. Follow the administration instructions to ensure treatment effectiveness.
Substance: dorzolamide + timolol
Date of last drug list: 01-06-2025
Commercial code: W66265001
Concentration: 20mg / 5mg / ml
Pharmaceutical form: ophthalmic drops solution
Quantity: 1
Product type: generic
Price: 32.82 RON
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Manufacturer: PHARMATHEN S.A. - GRECIA
Holder: SIFI S.P.A. - ITALIA
Number: 10640/2018/01
Shelf life: 2 years-after packing for marketing; after the first opening-28 de days
GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)
Price
Copayment
Patient
32.82 RON
32.82 RON
0.00 RON